95 related articles for article (PubMed ID: 12808344)
1. Persistence of the nitric oxide pathway in the aorta of hypercholesterolemic apolipoprotein-E-deficient mice.
Villeneuve N; Fortuno A; Sauvage M; Fournier N; Breugnot C; Jacquemin C; Petit C; Gosgnach W; Carpentier N; Vanhoutte P; Vilaine JP
J Vasc Res; 2003; 40(2):87-96. PubMed ID: 12808344
[TBL] [Abstract][Full Text] [Related]
2. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice.
Bonthu S; Heistad DD; Chappell DA; Lamping KG; Faraci FM
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2333-40. PubMed ID: 9409199
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice.
d'Uscio LV; Baker TA; Mantilla CB; Smith L; Weiler D; Sieck GC; Katusic ZS
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1017-22. PubMed ID: 11397713
[TBL] [Abstract][Full Text] [Related]
4. Augmented superoxide production by Nox2-containing NADPH oxidase causes cerebral artery dysfunction during hypercholesterolemia.
Miller AA; De Silva TM; Judkins CP; Diep H; Drummond GR; Sobey CG
Stroke; 2010 Apr; 41(4):784-9. PubMed ID: 20167907
[TBL] [Abstract][Full Text] [Related]
5. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity.
d'Uscio LV; Milstien S; Richardson D; Smith L; Katusic ZS
Circ Res; 2003 Jan; 92(1):88-95. PubMed ID: 12522125
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice.
Chen J; Kuhlencordt P; Urano F; Ichinose H; Astern J; Huang PL
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):97-103. PubMed ID: 12524231
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice.
Judkins CP; Diep H; Broughton BR; Mast AE; Hooker EU; Miller AA; Selemidis S; Dusting GJ; Sobey CG; Drummond GR
Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H24-32. PubMed ID: 19837950
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.
Ozaki M; Kawashima S; Yamashita T; Hirase T; Namiki M; Inoue N; Hirata K; Yasui H; Sakurai H; Yoshida Y; Masada M; Yokoyama M
J Clin Invest; 2002 Aug; 110(3):331-40. PubMed ID: 12163452
[TBL] [Abstract][Full Text] [Related]
9. Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein e-deficient mice.
d'Uscio LV; Smith LA; Katusic ZS
Stroke; 2001 Nov; 32(11):2658-64. PubMed ID: 11692031
[TBL] [Abstract][Full Text] [Related]
10. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
11. Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice.
Kauser K; da Cunha V; Fitch R; Mallari C; Rubanyi GM
Am J Physiol Heart Circ Physiol; 2000 May; 278(5):H1679-85. PubMed ID: 10775149
[TBL] [Abstract][Full Text] [Related]
12. Endothelial function in aorta segments of apolipoprotein E-deficient mice before development of atherosclerotic lesions.
Fransen P; Van Assche T; Guns PJ; Van Hove CE; De Keulenaer GW; Herman AG; Bult H
Pflugers Arch; 2008 Feb; 455(5):811-8. PubMed ID: 17899169
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
14. Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes.
't Hoen PA; Van der Lans CA; Van Eck M; Bijsterbosch MK; Van Berkel TJ; Twisk J
Circ Res; 2003 Aug; 93(3):262-9. PubMed ID: 12829615
[TBL] [Abstract][Full Text] [Related]
15. Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice.
Yamashiro K; Milsom AB; Duchene J; Panayiotou C; Urabe T; Hattori N; Ahluwalia A
J Cereb Blood Flow Metab; 2010 Aug; 30(8):1494-503. PubMed ID: 20234380
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice.
Kuhlencordt PJ; Padmapriya P; Rützel S; Schödel J; Hu K; Schäfer A; Huang PL; Ertl G; Bauersachs J
Atherosclerosis; 2009 Jan; 202(1):48-57. PubMed ID: 18479686
[TBL] [Abstract][Full Text] [Related]
17. Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI.
Crauwels HM; Van Hove CE; Holvoet P; Herman AG; Bult H
Cardiovasc Res; 2003 Jul; 59(1):189-99. PubMed ID: 12829190
[TBL] [Abstract][Full Text] [Related]
18. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
19. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice.
Kuhlencordt PJ; Gyurko R; Han F; Scherrer-Crosbie M; Aretz TH; Hajjar R; Picard MH; Huang PL
Circulation; 2001 Jul; 104(4):448-54. PubMed ID: 11468208
[TBL] [Abstract][Full Text] [Related]
20. Decreased sensitivity to nitric oxide in the aorta of severely hypercholesterolemic apolipoprotein E-deficient mice.
Yaghoubi M; Oliver-Krasinski J; Cayatte AJ; Cohen RA
J Cardiovasc Pharmacol; 2000 Dec; 36(6):751-7. PubMed ID: 11117375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
